Read More The US Food and Drug Administration has approved Novo Nordisks once-daily weight-loss pill, making it the first oral glucagon-like peptide 1 (GLP-1) product available for weight management
GLP-1 medications stimulate the pancreas to release more insulin, which helps decrease blood glucose
Initial studies in rats caused concerns over GLP-1 RAs causing thyroid cancer, but human studies are less clear on whether it is a concern.[ref] Decreased risk of substance abuse: A large 2026 study using data from the VA showed that GLP-1 RA drugs reduce the risk of developing a substance addiction (drugs, alcohol)
As described in peer-reviewed literature, CJC-1295 without DAC is a synthetic analog of growth hormone-releasing hormone (GHRH) studied for its role in pulsatile GH secretion dynamics in laboratory models (academic.oup.com)
Highly specific epigenome editing by CRISPRCas9 repressors for silencing of distal regulatory elements
Tendon Fibroblast Migration A study using rat Achilles-tendon fibroblasts reported altered outgrowth, migration and signalling associated with FAK and paxillin
